Observational and multinational study to characterize the use and efficacy of abemaciclib in patients with metastatic breast cancer.
OBSERVATIONAL STUDY WITH MEDICATION
Clinical trial information
- Promoter: LILLY, SA
- Execution start: 23/09/2022
- End of execution: 30/12/2023
- IP: ISABEL BLANCAS LOPEZ-BARAJAS